The Promise of the Ring (image) International Partnership for Microbicides (IPM) Share Print E-Mail Caption This World AIDS Day, women have reason to be optimistic that a new era may be at hand - one in which they could have more choices to protect themselves against HIV. Earlier this year, a novel monthly vaginal ring developed by the International Partnership for Microbicides became the first long-acting method to show efficacy in two Phase III clinical trials. Watch this video to learn about the dapivirine ring and IPM's next steps to potentially put the discreet, self-initiated product into the hands of women at high risk for HIV. Credit copyright 2016 IPM Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.